ICI alone (4284 patients), ICI-RT was associated with a marginally statistically significant benefit in 3-year OS (RR 0.90, (95% CI 0.82–0.99) p = 0.04) (NNT = 12).
← all excerpts
Beyond Abscopal Effect: A Meta-Analysis of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer.
1
0.0400
0.0400